Citigroup Maintains Neutral on Bruker, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 56.4%

Neg 0% Neu 0% Pos 56.4%

Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $44 to $60.